SCHEMBL29624959

SCHEMBL29624959

Cc1c(NC(=O)C(C)(C)C)ccc(Cl)c1C(F)(F)F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK1 Q15118 10/20 0.46
PDK2 Q15119 10/20 0.46
PDK3 Q15120 10/20 0.46
PDK4 Q16654 10/20 0.46
LMNA P02545 2/20 0.43
POLB P06746 2/20 0.43
MEN1 O00255 1/20 0.42
RAB9A P51151 1/20 0.42
KMT2A Q03164 1/20 0.42
HTT P42858 2/20 0.41
LCK P06239 1/20 0.41
KDR P35968 1/20 0.41
JAK3 P52333 1/20 0.41
MAPK14 Q16539 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MAPT P10636 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
CETP P11597 1/20 0.40
AR P10275 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1291381 1.00 PDK1 (0.46) PDK1PDK2PDK3PDK4LMNA
SCHEMBL13482713 0.84 L3MBTL1 (0.43) PDK1PDK2PDK3PDK4LMNA
SCHEMBL2432483 0.84 MEN1 (0.44) PDK1PDK2PDK3PDK4LMNA
SCHEMBL25368134 0.83 L3MBTL1 (0.42) PDK1PDK2PDK3PDK4LMNA
SCHEMBL14637963 0.81 LMNA (0.46) PDK1PDK2PDK3PDK4LMNA
SCHEMBL30681715 0.81 LMNA (0.46) PDK1PDK2PDK3PDK4LMNA
SCHEMBL23844276 0.81 LMNA (0.41) PDK1PDK2PDK3PDK4LMNA
SCHEMBL4417950 0.81 PDK1 (0.41) PDK1PDK2PDK3PDK4LMNA
SCHEMBL5407222 0.79 PDK1 (0.48) PDK1PDK2PDK3PDK4LMNA
SCHEMBL2430587 0.79 PDK1 (0.42) PDK1PDK2PDK3PDK4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022053010-A1 FUSED RING PYRIMIDONE DERIVATIVES FOR USE IN THE TREATMENT OF HBV INFECTION OR OF HBV-INDUCED DISEASES Janssen Sciences Ireland Unlimited Company (IE) 2022-03-17 WO disclosed